# Nonhealing Diabetic Foot Ulcers Treated With Standard of Care (SOC) Alone or Standard of Care and Amnion-Intermediate-Chorion (AIC)

> **NCT07014176** · PHASE4 · RECRUITING · sponsor: **Cellution Biologics** · enrollment: 120 (estimated)

## Conditions studied

- Diabetic Foot Ulcer

## Interventions

- **OTHER:** Amnion-Intermediate-Chorion
- **PROCEDURE:** Standard of Care (SOC)

## Key facts

- **NCT ID:** NCT07014176
- **Lead sponsor:** Cellution Biologics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-07-03
- **Primary completion:** 2026-06-30
- **Final completion:** 2026-10-31
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2025-10-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07014176

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07014176, "Nonhealing Diabetic Foot Ulcers Treated With Standard of Care (SOC) Alone or Standard of Care and Amnion-Intermediate-Chorion (AIC)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07014176. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*